SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remedies informs about clarification with regards to financial results

25 Oct 2022 Evaluate
Shree Ganesh Remedies has clarified that the Cash Flow statement submitted as at 30th September, 2022 contains the corresponding figures of 31st March 2022, however in the heading it is inadvertently mentioned as 31st March 2021, which is to be read as 31st March 2022. The updated copy of the financial results along with the cash flow statement is attached for ready reference, members are further request to note that there are no changes in the published figures.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remed. Share Price

533.90 26.70 (5.26%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×